Back    Zoom +    Zoom - Top
Citi: CN's Centralized Drug Procurement Helps Industry Consolidation, Favors Pharma Leaders in Near Term
Recommend
54
Positive
126
Negative
76
2019/07/15 14:36
Citigroup in its report cited Chinese media that National Healthcare Security Administration had on 12 July called a meeting with corporate attendance, proposing updated rules and expansion of centralized procurement. Drugs that partook in the first round (December 2018) will tender again at end-2019.

The broker opined that this move should accelerate industry consolidation next year, which favors the stock prices of domestic pharma leaders in a short run.

Related NewsBofAML: CN Adopts Elimination in 3rd Round GPO, May Bring Bigger Drug Price Cut Pressure

AAStocks Financial News
Web Site: www.aastocks.com